May 09th 2012
Prof. Mark Enright “Taking a Zero Tolerance Approach to Preventable Surgical Site Infection”
MoreApril 17th 2012
Dr. David Harper at the CHI Antibacterial Drug Development Meeting
MoreMarch 26th 2012
Dr. David Harper at Society for General Microbiology Spring Conference 2012
MoreMarch 12th 2012
Professor Mark Enright to present at University of Bath
MoreMarch 12th 2012
Professor Mark Enright to present at University of Bath
MoreNovember 08th 2011
Dr. David Harper to present at GTC Infectious Diseases World Summit
MoreSeptember 13th 2011
Ampliphi Biosciences Corp at Rodman and Renshaw Global Investment Conference
MoreFebruary 18th 2011
Targeted Genetics Annual Shareholder Meeting Business Update Presentation
MoreLatest News
March 27th 2012
“Using Viruses to Beat Superbugs,” AmpliPhi CSO Dr. David Harper featured in ScienceDaily
MoreMarch 08th 2012
“The Bacteriophage Comes of Age” in Medscape News
MoreJanuary 31st 2012
January 2012 Shareholder Letter
MoreJanuary 04th 2012
BioWorld Today features AmpliPhi CEO Phil Young
MoreNovember 21st 2011
AmpliPhi Biosciences Announces First Closing of $2.7m
More